When do models of NeuroAIDS faithfully imitate "the real thing"?

Journal of NeuroVirology

Volumn 24, Issue 2, 2018, Pages 146-155

  Gelman, Benjamin B ^a   Endsley, Janice ^a   Kolson, Dennis ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

ART; CNS; Dementia; Eradication; HAND; HIV; Latency

Indexed keywords

VIRUS DNA; VIRUS RNA; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTIVIRUS AGENT; BIOLOGICAL MARKER; CD163 ANTIGEN; CELL SURFACE RECEPTOR; CYTOKINE; DIFFERENTIATION ANTIGEN; ISG15 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PECAM1 PROTEIN, HUMAN; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1; UBIQUITIN;

CENTRAL NERVOUS SYSTEM; DISORDERS OF HIGHER CEREBRAL FUNCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT PERIOD; NERVE DEGENERATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ANIMAL; BRAIN; COGNITIVE DEFECT; DISEASE MODEL; DRUG EFFECT; GENETICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; PATHOGENICITY; PHYSIOLOGY; SYNAPTIC TRANSMISSION; VIROLOGY; VIRUS LATENCY;

AIDS DEMENTIA COMPLEX; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; BIOMARKERS; BRAIN; CENTRAL NERVOUS SYSTEM; COGNITIVE DYSFUNCTION; CYTOKINES; DISEASE MODELS, ANIMAL; HIV-1; HUMANS; NEUROTRANSMITTER AGENTS; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE-1; RECEPTORS, CELL SURFACE; SYNAPTIC TRANSMISSION; UBIQUITINS; VIRUS LATENCY;

EID: 85038399491     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-017-0601-5     Document Type: Review

References (60)

1. Abdulle S, Mellgren Å, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gisslén M (2007) CSF neurofilament protein (NFL)—a markerofactive HIV-related neurodegeneration. J Neurol 254(8):1026–1032. https://doi.org/10.1007/s00415-006-0481-8
2. Ancuta P, Kamat A, Kunstman KJ, Kim E-Y, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3(6):e2516. https://doi.org/10.1371/journal.pone.0002516
3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789–1799. https://doi.org/10.1212/01.WNL.0000287431.88658.8b
4. Baxter AE, Russel RA, Duncan CJA, Moore MD, Willberg CB, Pablos JL, Finzi A, Kaufmann DE (2014) Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host Microbe 16(6):711–721. https://doi.org/10.1016/j.chom.2014.10. 010
5. Beck SE, Queen SE, Witwer KW, Metcalf Pate KA, Mangus LM, Gama L, Adams RJ, Clements JE, Zink MC, Mankowski JL (2015a) Paving the path to HIV neurotherapy: predicting CD4+ T cells. Cell host Microbe 16(6):711–721. https://doi.org/10.1016/j.chom. 2014.10.010
6. Beck SE, Queen SE, Witwer KW, Metcalf Pate KA, Mangus LM, Gama L, Adams RJ, Clements JE, Zink MC, Mankowski JL (2015b) Paving the path to HIV neurotherapy: SIV CNS disease. Eur J Pharmacol 759:303–312. https://doi.org/10.1016/j.ejphar.2015.03. 018
7. Brew B (2010) Benefit or toxicity from neurologically targeted antiretroviral therapy? Clin infect Dis 50:930–932. https://doi.org/10.1086/650744
8. Bruner KM, Murray AJ, Pollack RA, Soliman MG, Laskey SB, Capoferri AA, Lai J, Strain MC, Lada SM, Hoh R, Ho YC, Richman DD, Deeks SG, Siliciano JD, Siliciano RF (2016) Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med 22(9): 1043–1049. https://doi.org/10.1038/nm.4156
9. Buzhdygan T, Lisinicchia J, Patel V, Johnson K, Neugebauer V, Paessler S, Jennings K, Gelman BB (2016) Neuropsychological, neurovirological and neuroimmune aspects of abnormal GABAergic transmission in HIV infection. J NeuroImmune Pharmacol 11(2):279–293. https://doi.org/10.1007/s11481-016-9652-2
10. Calantone N, Wu F, Klase Z, Deleage C, Perkins M, Matsuda K, Thompson EA, Ortiz AM, Vinton CL, Ourmanov I, Loré K, Douek DC, Estes JD, Hirsch VM, Brenchley JM (2014) Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells. Immunity 41(3):493–502. https://doi.org/10.1016/j.immuni.2014.08.014
11. Carroll A, Brew B (2017) HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment. F1000Research 2017 6(F1000 faculty rev):312. 10.12688/ f1000research.10651.1
12. Chen JY, Feeney ER, Chung RT (2014) HCV and HIV co-infection: mechanisms and management. Nat rev Gastroenterol Hepatol 11(6):362–371. https://doi.org/10.1038/nrgastro.2014.17
13. Chun T-W, Fauci AS (1999) Latent reservoirs of HIV: obstacles to the eradication of virus. ProcNatlAcadSci U S A 96(20):10958–10961
14. Clifford DB, Ances BM (2013) HIV-associated neurocognitive disorder (HAND). Lancet Infect Dis 13(11):976–986. https://doi.org/10. 1016/S1473-3099(13)70269-X
15. de Gaetano DK, Rabagliati R, Iacoviello L, Cauda R (2004) HIV infection, HAART, and endothelial adhesion molecules: current perspectives. Lancet Infect Dis 4(4):213–222. https://doi.org/10. 1016/S1473-3099(04)00971-5
16. DiNapoli SR, Ortiz AM, Wu F, Matsuda K, Twigg HL, Hirsch VM, Knox K, Brenchley JM (2017) Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected asian macaques. JCI Insight 2(4):e91214. https://doi.org/10.1172/jci.insight.91214
17. Eden A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, Price RW, Gisslén M (2010) HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J Infect Dis 202(12):1819–1825. https://doi.org/10.1086/657342
18. Edén A, Nilsson S, Hagberg L, Fuchs D, Zetterberg H, SvennerholmB GM (2016) Asymptomatic cerebrospinal fluid HIV-1 viral blips and viral escape during antiretroviral therapy: a longitudinal study. J Infect Dis 214(12):1822–1825. https://doi.org/10.1093/infdis/jiw454
19. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA (1997) Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 42(5):679– 668. https://doi.org/10.1002/ana.410420503
20. Ellis RJ, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nature Rev Neurosci 8:33–44. https://doi.org/10.1038/nrn2040
21. Fischer-Smith T, Tedaldi EM, Rappaport J (2008) CD163/CD16 co-expression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS res hum Retroviruses 24(3):417–421. https://doi.org/10.1089/aid.2007.0193
22. Gama L, Abreu CM, Shirk EN, Price SL, Li M, Laird GM, Pate KA, Wietgrefe SW, O'Connor SL, Pianowski L, Haase AT, Van Lint C, Siliciano RF, Clements JE, LRA-SIV Study Group (2017) Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. AIDS 31(1):5–14. https://doi.org/10.1097/QAD.0000000000001267
23. Gelman BB, Chen T, Lisinicchia JG, Soukup VM, Carmical JR, Starkey JM, Masliah E, Commins DL, Brandt D, Grant I, Singer EJ, Levine AJ, Miller J, Winkler JM, Fox HS, Luxon BA, Morgello S, National NeuroAIDS Tissue Consortium (2012a) The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS ONE 7(9):e46178. https://doi. org/10.1371/journal.pone.0046178
24. Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH Jr, Soukup VM (2012b) Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmaco l7:686. https://doi.org/10.1007/s11481-012-9345-4
25. Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, Fox HS, Kolson DL, Grant I, Singer E, Yiannoutsos CT, Sherman S, Gensler G, Moore DJ, Chen T, Soukup VM (2013) Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir immune Defic Syndr 62(5):487–495. https://doi.org/10.1097/QAI. 0b013e31827f1bdb
26. Gelman BB (2015) Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered. Curr HIV/AIDS Rep 12(2):272–279. https://doi.org/10.1007/s11904-015-0266-8
27. Gill AJ, Kolson DL (2014) Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence. Curr HIV/AIDS Rep 11(3):325–335. https://doi.org/10.1007/s11904-014-0210-3
28. Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H (2015) Plasma concentration of the neurofilamentlight protein (NFL) is a biomarker of CNS injury in HIV infection: across-sectional study. EBioMedicine 3:135–140. https://doi.org/10.1016/j.ebiom.2015.11.036
29. Gray R, Roche M, Flynn JK (2014) Is the central nervous system a reservoir of HIV-1? CurrOpin HIV AIDS 9(6):552–558. https://doi.org/10.1097/COH.0000000000000108
30. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75(23):2087– 2096. https://doi.org/10.1212/WNL. 0b013e318200d727
31. Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I, for the CHARTER Group, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Franklin D, Ellis RJ, McCutchan JA, Alexander T, Letendre S, Capparelli E, Heaton RK, Atkinson JH, Woods SP, Dawson M, Smith DM, Fennema-Notestine C, Taylor MJ, Theilmann R, Gamst AC, Cushman C, Abramson I, Vaida F, Marcotte TD, Marquie-Beck J, McArthur J, Rogalski V, Morgello S, Simpson D, Mintz L, McCutchan JA, Toperoff W, Collier A, Marra C, Jones T, Gelman B, Head E, Clifford D, al-Lozi M, Teshome M (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60(3): 473–480. https://doi.org/10.1093/cid/ciu862
32. Henrich TJ, Deeks SG, Pillai SK (2017) Measuring the size of the latent human immunodeficiency virus reservoir: the present and future of evaluating eradication strategies. J Infect Dis 215(suppl_3):S134– S141. https://doi.org/10.1093/infdis/jiw648
33. Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, CHARTER Study Group (2016) Anemia and red blood cell indices predict HIV-associated neurocognitive impairment in the highly active antiretroviral therapy era. J Infect Dis 213(7):1065–1073. https://doi.org/10.1093/infdis/jiv754
34. Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D (2012) Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. J Acquir Immune DeficSyndr 60(3):234–243. https://doi.org/10. 1097/QAI.0b013e318256f3bc
35. Kim WK, Alvarez X, Fisher J, Bronfin B, Westmoreland S, McLaurin J, Williams K (2006) CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am J Pathol 168(3):822–834. https://doi.org/10.2353/ajpath.2006.050215
36. Kugathasan R, Collier DA, Haddow LJ, El Bouzidi K, Edwards SG, Cartledge JD, Miller RF, Gupta RK (2017) Diffuse white matter signal abnormalities on magnetic resonance imaging are associated with human immunodeficiency virus type 1 viral escape in the central nervous system among patients with neurological symptoms. Clin infect Dis 64(8):1059–1065. https://doi.org/10.1093/cid/cix035
37. Lamers SL, Rose R, Maidji E, Agsalda-Garcia M, Nolan DJ, Fogel GB, Salemi M, Garcia DL, Bracci P, Yong W, Commins D, Said J, Khanlou N, Hinkin CH, Sueiras MV, Mathisen G, Donovan S, Shiramizu B, Stoddart CA, McGrath MS, Singer EJ et al (2016) HIV DNA is frequently present within pathologic tissues evaluated at autopsy from cART-treated patients with undetectable viral load. J Virol 90(20):8968–8983. https://doi.org/10.1128/JVI.00674-16
38. Le Douce, V, Herbein G, Rohr O, Schwartz, C (2010). Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 7:32. doi: https://doi.org/10.1186/1742–4690–7-32
39. Lee PK, Kieffer TL, Siliciano RF, Nettles RE (2006). HIV-1 viral load blips are of limited clinical significance. J Antimicrob Chemother 57(5):803-805. doi:https://doi.org/10.1093/jac/dkl092
40. Manji H, Jäger HR, Winston A (2013) HIV, dementia and antiretroviral drugs: 30 years of an epidemic. J NeurolNeurosurg Psychiatry 84(10):1126–1137. https://doi.org/10.1136/jnnp-2012-304022
41. Marban C, Forouzanfar F, Ait-Ammar A, Fahmi F, El Mekdad H, Daouad F, Rohr O, Schwartz C (2016) Targeting the brain reservoirs: toward an HIV cure. Front Immunol 7:397. https://doi.org/10.3389/fimmu. 2016.00397
42. McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67(6):699–714. https://doi.org/10.1002/ana.22053
43. Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons J, Chalkias S, Wurcel A, Burke D, Venna N, Morgello S, Koralnik IJ, Gabuzda D (2017) Temporal patterns and drug resistance in CSF viral escape among ART-experienced HIV-1 infected adults. J Acquir Immune DeficSyndr 75:246–255. https://doi.org/10.1097/QAI.0000000000001362
44. Nettles RE, Kieffer TL, Kwon P, Monie D, Han Y, Parsons T, Cofrancesco J Jr, Gallant JE, Quinn TC, Jackson B, Flexner C, Carson K, Ray S, Persaud D, Siliciano RF (2005) Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. JAMA 293(7):817–829. https://doi.org/10.1001/jama. 293.7.817
45. Okumura A, Lu G, Pitha-Rowe I, Pitha PM (2006) Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. ProcNatlAcadSci 103(5):1440–1445. https://doi.org/10. 1073/pnas.0510518103
46. Ragin AB, Wu Y, Gao Y, Keating S, Du H, Sammet C, Kettering CS, Epstein LG (2015) Brain alterations within the first 100 days of HIV infection. Ann ClinTranslNeurol 2(1):12–21. https://doi.org/10. 1002/acn3.136
47. Rawson T, Muir D, Mackie NE, Garvey LJ, Everitt A, Winston A (2012) Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting. J Inf Secur 65(3):239–245. https://doi.org/10.1016/j.jinf. 2012.04.007
48. Russell RA, Chojnacki J, Jones DM, Johnson E, Do T, Eggeling C, Padilla-Parra S, Sattentau QJ (2017) Astrocytes resist HIV-1 fusion but engulf infected macrophage material. Cell Rep 18(6):1473– 1483. https://doi.org/10.1016/j.celrep.2017.01.027
49. Sanford R, Fernandez Cruz AL, Scott S, Mayo NE, Fellows LK, Ances BM, Collins DL (2017) Regionally specific brain volumetric and cortical thickness changes in HIV-infected patients in the HAART era. J Acquir Immune DeficSyndr 74(5):563–570. https://doi.org/10.1097/QAI.0000000000001294
50. Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder—pathogenesis and prospects for treatment. Nat Rev Neurol 12(4):234–248. https://doi.org/10.1038/nrneurol.2016.27
51. Schuster RM, Gonzalez R (2012) Substance abuse, hepatitis C, and aging in HIV: common cofactors that contribute to neurobehavioral disturbances. Neurobehav HIV Med 2012(4):15–34. https://doi.org/10. 2147/NBHIV.S17408
52. Siliciano JM, Siliciano RF (2015) The remarkable stability of the latent reservoir for HIV-1 in resting memory CD4+ T cells. J Infect Dis 212(9):1345–1347. https://doi.org/10.1093/infdis/jiv219
53. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24(9):1243–1250. https://doi.org/10.1097/QAD.0b013e3283354a7b
54. Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B, Fuchs D, Tambussi G, Cinque P, Hecht FM, Price RW (2011) Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infec Dis 204(5):753–760. https://doi. org/10.1093/infdis/jir387
55. Stevenson M (2017) HIV persistence in macrophages. Nat Med 23(5): 538–539. https://doi.org/10.1038/nm.4337
56. Tan IL, McArthur JC (2012) HIV-associated neurological disorders. A guide to pharmacotherapy. CNS Drugs 26(2):123–134. https://doi. org/10.2165/11597770-000000000-00000
57. Vera JH, Ridha B, Gilleece Y, Amlani A, Thorburn P, Dizdarevic S (2017) PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy. Eur J NuclMedMolImaging44:895–902. https://doi.org/10.1007/s00259-016-3602-3
58. Wiley CA, Achim C (1994) Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 36(4):673–676. https://doi.org/10. 1002/ana.410360422
59. Wolf K, Tsakiris DA, Weber R, Erb P, Battegay M, Swiss HIV Cohort Study (2002) Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis 185(4):456–462. https://doi. org/10.1086/338572
60. Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM (2016) Putamen volume and its clinical and neurological correlates in primary HIV infection. AIDS 30(11):1789–1794. https://doi.org/10.1097/QAD.0000000000001103